首页> 美国卫生研究院文献>NPG Open Access >Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus
【2h】

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus

机译:与14号染色体获得性单亲二体性相关的深远父母偏见表明目标是印迹位点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acquired uniparental disomy (aUPD) is a common finding in myeloid malignancies and typically acts to convert a somatically acquired heterozygous mutation to homozygosity. We sought to identify the target of chromosome 14 aUPD (aUPD14), a recurrent abnormality in myeloid neoplasms and population cohorts of elderly individuals. We identified 29 cases with aUPD14q that defined a minimal affected region (MAR) of 11.2 Mb running from 14q32.12 to the telomere. Exome sequencing (n=7) did not identify recurrently mutated genes, but methylation-specific PCR at the imprinted MEG3-DLK1 locus located within the MAR demonstrated loss of maternal chromosome 14 and gain of paternal chromosome 14 (P<0.0001), with the degree of methylation imbalance correlating with the level of aUPD (r=0.76; P=0.0001). The absence of driver gene mutations in the exomes of three individuals with aUPD14q but no known haematological disorder suggests that aUPD14q may be sufficient to drive clonal haemopoiesis. Analysis of cases with both aUPD14q and JAK2 V617F (n=11) indicated that aUPD14q may be an early event in some cases but a late event in others. We conclude that aUPD14q is a recurrent abnormality that targets an imprinted locus and may promote clonal haemopoiesis either as an initiating event or as a secondary change.
机译:获得性单亲二体性(aUPD)是髓样恶性肿瘤的常见发现,通常用于将体细胞获得的杂合突变转化为纯合性。我们力图确定第14号染色体aUPD(aUPD14)的靶标,这是髓样肿瘤的复发异常和老年人群的队列。我们确定了29例aUPD14q,它们定义了从14q32.12到端粒的最小受影响区域(MAR)为11.2 ofMb。外显子组测序(n = 7)不能识别出重复突变的基因,但是位于MAR内的印迹MEG3-DLK1位点的甲基化特异性PCR证明了母亲染色体14的缺失和父亲染色体14的获得(P <0.0001),甲基化失衡的程度与aUPD的水平相关(r = 0.76; P = 0.0001)。在三个患有aUPD14q的个体的外显子组中不存在驱动基因突变,但没有已知的血液学疾病提示aUPD14q可能足以驱动克隆性造血。对同时使用aUPD14q和JAK2 V617F(n = 11)的案例进行的分析表明,aUPD14q在某些情况下可能是早期事件,而在另一些情况下则是晚期事件。我们得出的结论是,aUPD14q是一种复发性异常,其目标是一个印迹基因座,并且可能作为起始事件或继发性变化而促进克隆性造血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号